Skip to content

Abivax S.A.

AAVXF ABVX

CIK 0001956827

← back to feed
Revenue (TTM)
—
FY Dec 2025
Net Income (TTM)
−€309.37M
−90.7% YoY FY Dec 2025
EPS Diluted (TTM)
−€4.56
−72.5% YoY FY Dec 2025
Gross Margin
—
FY Dec 2025
Operating Margin
—
FY Dec 2025
Net Margin
—
FY Dec 2025
Free Cash Flow (TTM)
—
FY Dec 2025
Cash
€516.69M
FY Dec 2025
Total Debt
—
FY Dec 2025
Shares Outstanding
78.54M sh
FY Dec 2025

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings